EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Andras Fogarasi, Liesbeth De Waele, Gabriella Bartalini, Sergiusz Jozwiak, Nicola Laforgia, Helene Verhelst, Borivoj Petrak, Jean-Michel Pedespan, Olaf Witt, Ramon Castellana, Stefania Crippa, Gabriella Gislimberti, Zsuzsanna Gyorsok

ABSTRACT

BACKGROUND: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be effective and safe in the treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC). The Everolimus For Fast Expanded aCcess in TSC SEGA (EFFECTS) study was designed to provide everolimus access to patients with SEGA associated with TSC and to mainly assess the safety and also efficacy of everolimus in a real-world setting. METHODS: EFFECTS was a phase 3b, open-label, noncomparative, multicenter, expanded access study. Eligible patients were ≥ 3 years of age, with a definite diagnosis of TSC, and with at least one SEGA lesion identified by MRI or CT scan. Patients received once daily everolimus (dose adjusted to attain a trough level of 5-15 ng/mL). Safety evaluation was the primary objective and included collection of adverse events (AEs) and serious AEs, with their severity and relationship to everolimus. Efficacy evaluation, which was the secondary objective, was based on the best overall response as per medical judgment. RESULTS: Of the 120 patients enrolled, 100 (83.3%) completed the study. Median age of patients was 11 years (range, 1-47). Median daily dose of everolimus was 5.82 mg (range, 2.0-11.8). Median duration of exposure was 56.5 weeks (range, 0.3-130). The overall incidence of AEs was 74.2%. Aphthous stomatitis (18 [15.0%]), pyrexia (18 [15.0%]), bronchitis (11 [9.2%]), and stomatitis (10 [8.3%]) were the most common AEs reported. Overall, 25 patients had grade 3 AEs; most frequent was stomatitis (4 [3.3%]). Grade 4 AEs were reported in three (2.5%) patients. A total of 62 (51.7%) patients had suspected drug-related AEs, of which 15 (12.5%) were of grade 3 or 4. In eight (6.7%) patients, AEs led to drug discontinuation. With regard to efficacy, 81 (67.5%) patients had a partial response, 35 (29.2%) had a stable disease, and one (0.8%) had progressive disease. The response was unknown in three (2.5%) patients. CONCLUSION: This study confirms the acceptable safety profile of everolimus in patients with SEGA associated with TSC in a real-world setting. The results further support the efficacy of everolimus in the treatment of SEGA associated with TSC. (EudraCT: 2010-022583-13). More... »

PAGES

126

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4

DOI

http://dx.doi.org/10.1186/s12883-016-0658-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026098504

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27502586


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Astrocytoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bronchitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Everolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fever", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomatitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomatitis, Aphthous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tuberous Sclerosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Bethesda Gyermekk\u00f3rh\u00e1z", 
          "id": "https://www.grid.ac/institutes/grid.427987.7", 
          "name": [
            "Neurology Department, Bethesda Children\u2019s Hospital, Bethesda Street 3, H-1146, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fogarasi", 
        "givenName": "Andras", 
        "id": "sg:person.0717700043.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717700043.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universitaire Ziekenhuizen Leuven", 
          "id": "https://www.grid.ac/institutes/grid.410569.f", 
          "name": [
            "Gasthuisberg University Hospitals Leuven, Leuven, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Waele", 
        "givenName": "Liesbeth", 
        "id": "sg:person.01344505207.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344505207.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Senese", 
          "id": "https://www.grid.ac/institutes/grid.411477.0", 
          "name": [
            "Pediatric Unit, University Hospital, Siena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bartalini", 
        "givenName": "Gabriella", 
        "id": "sg:person.01076001116.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076001116.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical University of Warsaw", 
          "id": "https://www.grid.ac/institutes/grid.13339.3b", 
          "name": [
            "Children\u2019s Memorial Health Institute, Warsaw, Poland", 
            "Department of Pediatric Neurology, Medical University of Warsaw, Warsaw, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jozwiak", 
        "givenName": "Sergiusz", 
        "id": "sg:person.0761055735.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055735.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Bari Aldo Moro", 
          "id": "https://www.grid.ac/institutes/grid.7644.1", 
          "name": [
            "Neonatology and NICU Section, DIMO, University of Bari, Bari, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laforgia", 
        "givenName": "Nicola", 
        "id": "sg:person.0600321213.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600321213.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ghent University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410566.0", 
          "name": [
            "Ghent University Hospital, Ghent, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verhelst", 
        "givenName": "Helene", 
        "id": "sg:person.0665477047.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665477047.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital in Motol", 
          "id": "https://www.grid.ac/institutes/grid.412826.b", 
          "name": [
            "Motol University Hospital, Prague, Czech Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrak", 
        "givenName": "Borivoj", 
        "id": "sg:person.01313336275.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313336275.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Bordeaux", 
          "id": "https://www.grid.ac/institutes/grid.42399.35", 
          "name": [
            "CHU Pellegrin\u2013H\u00f4pital des Enfants, Bordeaux, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pedespan", 
        "givenName": "Jean-Michel", 
        "id": "sg:person.0731716626.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731716626.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "German Cancer Research Center and Section of Pediatric Brain Tumors, University Hospital, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Witt", 
        "givenName": "Olaf", 
        "id": "sg:person.01367420407.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367420407.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Spain)", 
          "id": "https://www.grid.ac/institutes/grid.476612.0", 
          "name": [
            "Novartis Farmac\u00e9utica SA, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castellana", 
        "givenName": "Ramon", 
        "id": "sg:person.016513102705.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016513102705.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Italy)", 
          "id": "https://www.grid.ac/institutes/grid.15585.3c", 
          "name": [
            "Novartis Farma S.p.A., Origgio, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crippa", 
        "givenName": "Stefania", 
        "id": "sg:person.010010031505.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010010031505.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (Italy)", 
          "id": "https://www.grid.ac/institutes/grid.15585.3c", 
          "name": [
            "Novartis Farma S.p.A., Origgio, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gislimberti", 
        "givenName": "Gabriella", 
        "id": "sg:person.01145056405.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145056405.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bethesda Gyermekk\u00f3rh\u00e1z", 
          "id": "https://www.grid.ac/institutes/grid.427987.7", 
          "name": [
            "Neurology Department, Bethesda Children\u2019s Hospital, Bethesda Street 3, H-1146, Budapest, Hungary", 
            "National Institute of Neurosciences, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gyorsok", 
        "givenName": "Zsuzsanna", 
        "id": "sg:person.01317050103.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317050103.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1100391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002019704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-0445", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003978738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpn.2012.12.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006752995"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00301665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007024239", 
          "https://doi.org/10.1007/bf00301665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/088307389801301206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012252699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/088307389801301206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012252699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2012.02.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012443339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/b978-0-444-52891-9.00038-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013632066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpn.2013.03.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015822271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.08.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017921616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61134-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019518465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.08.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024394203"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra055323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028026275"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(08)61279-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028138958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpn.2012.10.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028768098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1001671", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029275718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2013.281053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031488893"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20784", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032399558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20784", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032399558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00381-013-2170-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033912792", 
          "https://doi.org/10.1007/s00381-013-2170-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71101-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034717349"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.12.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036207371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)70489-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038475260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pediatrneurol.2013.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039003462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tem.2010.05.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045995641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61767-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047847005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.23960", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048919715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0030-1269906", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057233391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000142039.14522.1a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000142039.14522.1a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000142039.14522.1a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3182815428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3171/2013.9.peds13193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071079237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/157015912804143595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078738365"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be effective and safe in the treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC). The Everolimus For Fast Expanded aCcess in TSC SEGA (EFFECTS) study was designed to provide everolimus access to patients with SEGA associated with TSC and to mainly assess the safety and also efficacy of everolimus in a real-world setting.\nMETHODS: EFFECTS was a phase 3b, open-label, noncomparative, multicenter, expanded access study. Eligible patients were \u2265 3 years of age, with a definite diagnosis of TSC, and with at least one SEGA lesion identified by MRI or CT scan. Patients received once daily everolimus (dose adjusted to attain a trough level of 5-15 ng/mL). Safety evaluation was the primary objective and included collection of adverse events (AEs) and serious AEs, with their severity and relationship to everolimus. Efficacy evaluation, which was the secondary objective, was based on the best overall response as per medical judgment.\nRESULTS: Of the 120 patients enrolled, 100 (83.3%) completed the study. Median age of patients was 11 years (range, 1-47). Median daily dose of everolimus was 5.82 mg (range, 2.0-11.8). Median duration of exposure was 56.5 weeks (range, 0.3-130). The overall incidence of AEs was 74.2%. Aphthous stomatitis (18 [15.0%]), pyrexia (18 [15.0%]), bronchitis (11 [9.2%]), and stomatitis (10 [8.3%]) were the most common AEs reported. Overall, 25 patients had grade 3 AEs; most frequent was stomatitis (4 [3.3%]). Grade 4 AEs were reported in three (2.5%) patients. A total of 62 (51.7%) patients had suspected drug-related AEs, of which 15 (12.5%) were of grade 3 or 4. In eight (6.7%) patients, AEs led to drug discontinuation. With regard to efficacy, 81 (67.5%) patients had a partial response, 35 (29.2%) had a stable disease, and one (0.8%) had progressive disease. The response was unknown in three (2.5%) patients.\nCONCLUSION: This study confirms the acceptable safety profile of everolimus in patients with SEGA associated with TSC in a real-world setting. The results further support the efficacy of everolimus in the treatment of SEGA associated with TSC. (EudraCT: 2010-022583-13).", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12883-016-0658-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024950", 
        "issn": [
          "1471-2377"
        ], 
        "name": "BMC Neurology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex", 
    "pagination": "126", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7c54c9bd92ec8ec44f057d7e66a30cde1e0ba80ae9fd258382374f999a55b645"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27502586"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968555"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12883-016-0658-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026098504"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12883-016-0658-4", 
      "https://app.dimensions.ai/details/publication/pub.1026098504"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87088_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12883-016-0658-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12883-016-0658-4'


 

This table displays all metadata directly associated to this object as RDF triples.

367 TRIPLES      21 PREDICATES      82 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12883-016-0658-4 schema:about N0913e60aa0974e36a79ff1280cf17b8e
2 N14682c8a260c4fa286c348d8deaa7e51
3 N250565d18bb64a66b0dc432b87201a5c
4 N30b71c30010d4e5897b14a027baee16d
5 N344b076bac2942b7b065a2c5a4d44c8d
6 N522d78ab8d2f4eaf8e222f1587a5b970
7 N6e1c49a687954989bf1044ee55281af9
8 N75654d37c1654a18bbc7d7ce063f022b
9 N7fa277961c7845a8bcebb5d53862151e
10 N8d37496147cc4a68b477e31870bc2a25
11 N8d88b08887c240c6883ccdc49f833e2b
12 N9af14ddfd27c49d3a6bb1926dde5107b
13 N9e9219f1f82d4b7285d09f9a49a468b6
14 Na7af7ba86b9245fa8f3a8ae7f49ff9b4
15 Nb4b35e9aa9f0467a935e0c2523c0f1df
16 Nc02ee97455804fa9852792f0c69a7b2c
17 Nc387a8bf53894504ae05cb6e3d16731a
18 Ncbe392fb741c44748b18665f468e471c
19 Nd495d0683d184378a6d01832d8104132
20 Ne5bc99db1af949688ab9a055839cbac3
21 Nf989fdca40b04b828a355e9a69ce73e8
22 Nfaa69ccc132b46248fce92ab21af52de
23 Nfb4d6cd8d07c4c77ac40b0a8abb2a5af
24 anzsrc-for:11
25 anzsrc-for:1117
26 schema:author N1acca22cbd81475593533126f77e5e30
27 schema:citation sg:pub.10.1007/bf00301665
28 sg:pub.10.1007/s00381-013-2170-0
29 https://doi.org/10.1001/jama.2013.281053
30 https://doi.org/10.1002/ana.20784
31 https://doi.org/10.1002/ana.23960
32 https://doi.org/10.1016/b978-0-444-52891-9.00038-5
33 https://doi.org/10.1016/j.ejpn.2012.10.005
34 https://doi.org/10.1016/j.ejpn.2012.12.008
35 https://doi.org/10.1016/j.ejpn.2013.03.002
36 https://doi.org/10.1016/j.pediatrneurol.2012.02.015
37 https://doi.org/10.1016/j.pediatrneurol.2013.08.001
38 https://doi.org/10.1016/j.pediatrneurol.2013.08.002
39 https://doi.org/10.1016/j.pediatrneurol.2013.08.017
40 https://doi.org/10.1016/j.pediatrneurol.2013.12.004
41 https://doi.org/10.1016/j.tem.2010.05.003
42 https://doi.org/10.1016/s0140-6736(08)61279-9
43 https://doi.org/10.1016/s0140-6736(12)61134-9
44 https://doi.org/10.1016/s0140-6736(12)61767-x
45 https://doi.org/10.1016/s1470-2045(14)70489-9
46 https://doi.org/10.1016/s1470-2045(14)71101-5
47 https://doi.org/10.1055/s-0030-1269906
48 https://doi.org/10.1056/nejmoa1001671
49 https://doi.org/10.1056/nejmoa1100391
50 https://doi.org/10.1056/nejmra055323
51 https://doi.org/10.1158/1078-0432.ccr-11-0445
52 https://doi.org/10.1177/088307389801301206
53 https://doi.org/10.1212/01.wnl.0000142039.14522.1a
54 https://doi.org/10.1212/wnl.0b013e3182815428
55 https://doi.org/10.2174/157015912804143595
56 https://doi.org/10.3171/2013.9.peds13193
57 schema:datePublished 2016-12
58 schema:datePublishedReg 2016-12-01
59 schema:description BACKGROUND: Everolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been shown to be effective and safe in the treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC). The Everolimus For Fast Expanded aCcess in TSC SEGA (EFFECTS) study was designed to provide everolimus access to patients with SEGA associated with TSC and to mainly assess the safety and also efficacy of everolimus in a real-world setting. METHODS: EFFECTS was a phase 3b, open-label, noncomparative, multicenter, expanded access study. Eligible patients were ≥ 3 years of age, with a definite diagnosis of TSC, and with at least one SEGA lesion identified by MRI or CT scan. Patients received once daily everolimus (dose adjusted to attain a trough level of 5-15 ng/mL). Safety evaluation was the primary objective and included collection of adverse events (AEs) and serious AEs, with their severity and relationship to everolimus. Efficacy evaluation, which was the secondary objective, was based on the best overall response as per medical judgment. RESULTS: Of the 120 patients enrolled, 100 (83.3%) completed the study. Median age of patients was 11 years (range, 1-47). Median daily dose of everolimus was 5.82 mg (range, 2.0-11.8). Median duration of exposure was 56.5 weeks (range, 0.3-130). The overall incidence of AEs was 74.2%. Aphthous stomatitis (18 [15.0%]), pyrexia (18 [15.0%]), bronchitis (11 [9.2%]), and stomatitis (10 [8.3%]) were the most common AEs reported. Overall, 25 patients had grade 3 AEs; most frequent was stomatitis (4 [3.3%]). Grade 4 AEs were reported in three (2.5%) patients. A total of 62 (51.7%) patients had suspected drug-related AEs, of which 15 (12.5%) were of grade 3 or 4. In eight (6.7%) patients, AEs led to drug discontinuation. With regard to efficacy, 81 (67.5%) patients had a partial response, 35 (29.2%) had a stable disease, and one (0.8%) had progressive disease. The response was unknown in three (2.5%) patients. CONCLUSION: This study confirms the acceptable safety profile of everolimus in patients with SEGA associated with TSC in a real-world setting. The results further support the efficacy of everolimus in the treatment of SEGA associated with TSC. (EudraCT: 2010-022583-13).
60 schema:genre research_article
61 schema:inLanguage en
62 schema:isAccessibleForFree true
63 schema:isPartOf N907f6dd7c66b4ce38036f602e12011e9
64 Nf852f87b4f1b4a04ad4f91801139fc81
65 sg:journal.1024950
66 schema:name EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
67 schema:pagination 126
68 schema:productId N3370f1c59ff249d199124364f7f86d8a
69 N6a8597bd23e54166a1619784ab43132b
70 N6e30c9d385ee41d3b70595f36b255890
71 Na80f004ab28f430d91dae2afd89d5885
72 Ndd2b3c041fa042539350cb3d48b61e70
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026098504
74 https://doi.org/10.1186/s12883-016-0658-4
75 schema:sdDatePublished 2019-04-11T12:22
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher N6c6813a3587b4e8e9fb51221658180c0
78 schema:url https://link.springer.com/10.1186%2Fs12883-016-0658-4
79 sgo:license sg:explorer/license/
80 sgo:sdDataset articles
81 rdf:type schema:ScholarlyArticle
82 N075111489385487e928bc0c4d84dae06 rdf:first sg:person.01344505207.04
83 rdf:rest Ne8f6e6b2e9e2484297cd6a16223286f1
84 N0913e60aa0974e36a79ff1280cf17b8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Female
86 rdf:type schema:DefinedTerm
87 N14682c8a260c4fa286c348d8deaa7e51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Bronchitis
89 rdf:type schema:DefinedTerm
90 N1acca22cbd81475593533126f77e5e30 rdf:first sg:person.0717700043.03
91 rdf:rest N075111489385487e928bc0c4d84dae06
92 N1d5fc9bd45c64650a0da3b43afbd4806 rdf:first sg:person.010010031505.70
93 rdf:rest N53a47848497a4f62a3c473101254f169
94 N24abd9e684a14f9da978fcce388d2fd7 rdf:first sg:person.01367420407.26
95 rdf:rest Na0a0c8e23f5147ffa6e30344fa5f106a
96 N250565d18bb64a66b0dc432b87201a5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Middle Aged
98 rdf:type schema:DefinedTerm
99 N2f72a109968442b3bfa8d980f4ee2fea rdf:first sg:person.0761055735.36
100 rdf:rest N38f1cc277d3a4dd59864fe1a650bc734
101 N30b71c30010d4e5897b14a027baee16d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Male
103 rdf:type schema:DefinedTerm
104 N3370f1c59ff249d199124364f7f86d8a schema:name doi
105 schema:value 10.1186/s12883-016-0658-4
106 rdf:type schema:PropertyValue
107 N344b076bac2942b7b065a2c5a4d44c8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Treatment Outcome
109 rdf:type schema:DefinedTerm
110 N358c63ae70584679aeba42b50800e5fb rdf:first sg:person.01317050103.52
111 rdf:rest rdf:nil
112 N38f1cc277d3a4dd59864fe1a650bc734 rdf:first sg:person.0600321213.94
113 rdf:rest N48349b3b650542d99f86faa8e3dad2b7
114 N48349b3b650542d99f86faa8e3dad2b7 rdf:first sg:person.0665477047.21
115 rdf:rest Nda734ccd6229477f92af36df7cc58289
116 N4cea04ab56104e048f7d20b4cfc857e4 schema:name German Cancer Research Center and Section of Pediatric Brain Tumors, University Hospital, Heidelberg, Germany
117 rdf:type schema:Organization
118 N522d78ab8d2f4eaf8e222f1587a5b970 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Safety
120 rdf:type schema:DefinedTerm
121 N53a47848497a4f62a3c473101254f169 rdf:first sg:person.01145056405.34
122 rdf:rest N358c63ae70584679aeba42b50800e5fb
123 N6a8597bd23e54166a1619784ab43132b schema:name nlm_unique_id
124 schema:value 100968555
125 rdf:type schema:PropertyValue
126 N6c6813a3587b4e8e9fb51221658180c0 schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N6e1c49a687954989bf1044ee55281af9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Humans
130 rdf:type schema:DefinedTerm
131 N6e30c9d385ee41d3b70595f36b255890 schema:name dimensions_id
132 schema:value pub.1026098504
133 rdf:type schema:PropertyValue
134 N728eb055972a4726ae5fa78d4c338cba rdf:first sg:person.0731716626.13
135 rdf:rest N24abd9e684a14f9da978fcce388d2fd7
136 N75654d37c1654a18bbc7d7ce063f022b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Disease Progression
138 rdf:type schema:DefinedTerm
139 N7fa277961c7845a8bcebb5d53862151e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Everolimus
141 rdf:type schema:DefinedTerm
142 N8d37496147cc4a68b477e31870bc2a25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Adolescent
144 rdf:type schema:DefinedTerm
145 N8d88b08887c240c6883ccdc49f833e2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Child, Preschool
147 rdf:type schema:DefinedTerm
148 N907f6dd7c66b4ce38036f602e12011e9 schema:issueNumber 1
149 rdf:type schema:PublicationIssue
150 N9af14ddfd27c49d3a6bb1926dde5107b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Infant
152 rdf:type schema:DefinedTerm
153 N9e9219f1f82d4b7285d09f9a49a468b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Astrocytoma
155 rdf:type schema:DefinedTerm
156 Na0a0c8e23f5147ffa6e30344fa5f106a rdf:first sg:person.016513102705.92
157 rdf:rest N1d5fc9bd45c64650a0da3b43afbd4806
158 Na7af7ba86b9245fa8f3a8ae7f49ff9b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Fever
160 rdf:type schema:DefinedTerm
161 Na80f004ab28f430d91dae2afd89d5885 schema:name pubmed_id
162 schema:value 27502586
163 rdf:type schema:PropertyValue
164 Nb4b35e9aa9f0467a935e0c2523c0f1df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Antineoplastic Agents
166 rdf:type schema:DefinedTerm
167 Nc02ee97455804fa9852792f0c69a7b2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Stomatitis
169 rdf:type schema:DefinedTerm
170 Nc387a8bf53894504ae05cb6e3d16731a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Adult
172 rdf:type schema:DefinedTerm
173 Ncbe392fb741c44748b18665f468e471c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Young Adult
175 rdf:type schema:DefinedTerm
176 Nd495d0683d184378a6d01832d8104132 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Tuberous Sclerosis
178 rdf:type schema:DefinedTerm
179 Nda734ccd6229477f92af36df7cc58289 rdf:first sg:person.01313336275.27
180 rdf:rest N728eb055972a4726ae5fa78d4c338cba
181 Ndd2b3c041fa042539350cb3d48b61e70 schema:name readcube_id
182 schema:value 7c54c9bd92ec8ec44f057d7e66a30cde1e0ba80ae9fd258382374f999a55b645
183 rdf:type schema:PropertyValue
184 Ne5bc99db1af949688ab9a055839cbac3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Remission Induction
186 rdf:type schema:DefinedTerm
187 Ne8f6e6b2e9e2484297cd6a16223286f1 rdf:first sg:person.01076001116.87
188 rdf:rest N2f72a109968442b3bfa8d980f4ee2fea
189 Nf852f87b4f1b4a04ad4f91801139fc81 schema:volumeNumber 16
190 rdf:type schema:PublicationVolume
191 Nf989fdca40b04b828a355e9a69ce73e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Brain Neoplasms
193 rdf:type schema:DefinedTerm
194 Nfaa69ccc132b46248fce92ab21af52de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Stomatitis, Aphthous
196 rdf:type schema:DefinedTerm
197 Nfb4d6cd8d07c4c77ac40b0a8abb2a5af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Child
199 rdf:type schema:DefinedTerm
200 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
201 schema:name Medical and Health Sciences
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
204 schema:name Public Health and Health Services
205 rdf:type schema:DefinedTerm
206 sg:journal.1024950 schema:issn 1471-2377
207 schema:name BMC Neurology
208 rdf:type schema:Periodical
209 sg:person.010010031505.70 schema:affiliation https://www.grid.ac/institutes/grid.15585.3c
210 schema:familyName Crippa
211 schema:givenName Stefania
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010010031505.70
213 rdf:type schema:Person
214 sg:person.01076001116.87 schema:affiliation https://www.grid.ac/institutes/grid.411477.0
215 schema:familyName Bartalini
216 schema:givenName Gabriella
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076001116.87
218 rdf:type schema:Person
219 sg:person.01145056405.34 schema:affiliation https://www.grid.ac/institutes/grid.15585.3c
220 schema:familyName Gislimberti
221 schema:givenName Gabriella
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145056405.34
223 rdf:type schema:Person
224 sg:person.01313336275.27 schema:affiliation https://www.grid.ac/institutes/grid.412826.b
225 schema:familyName Petrak
226 schema:givenName Borivoj
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313336275.27
228 rdf:type schema:Person
229 sg:person.01317050103.52 schema:affiliation https://www.grid.ac/institutes/grid.427987.7
230 schema:familyName Gyorsok
231 schema:givenName Zsuzsanna
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317050103.52
233 rdf:type schema:Person
234 sg:person.01344505207.04 schema:affiliation https://www.grid.ac/institutes/grid.410569.f
235 schema:familyName De Waele
236 schema:givenName Liesbeth
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344505207.04
238 rdf:type schema:Person
239 sg:person.01367420407.26 schema:affiliation N4cea04ab56104e048f7d20b4cfc857e4
240 schema:familyName Witt
241 schema:givenName Olaf
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367420407.26
243 rdf:type schema:Person
244 sg:person.016513102705.92 schema:affiliation https://www.grid.ac/institutes/grid.476612.0
245 schema:familyName Castellana
246 schema:givenName Ramon
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016513102705.92
248 rdf:type schema:Person
249 sg:person.0600321213.94 schema:affiliation https://www.grid.ac/institutes/grid.7644.1
250 schema:familyName Laforgia
251 schema:givenName Nicola
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600321213.94
253 rdf:type schema:Person
254 sg:person.0665477047.21 schema:affiliation https://www.grid.ac/institutes/grid.410566.0
255 schema:familyName Verhelst
256 schema:givenName Helene
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665477047.21
258 rdf:type schema:Person
259 sg:person.0717700043.03 schema:affiliation https://www.grid.ac/institutes/grid.427987.7
260 schema:familyName Fogarasi
261 schema:givenName Andras
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717700043.03
263 rdf:type schema:Person
264 sg:person.0731716626.13 schema:affiliation https://www.grid.ac/institutes/grid.42399.35
265 schema:familyName Pedespan
266 schema:givenName Jean-Michel
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731716626.13
268 rdf:type schema:Person
269 sg:person.0761055735.36 schema:affiliation https://www.grid.ac/institutes/grid.13339.3b
270 schema:familyName Jozwiak
271 schema:givenName Sergiusz
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761055735.36
273 rdf:type schema:Person
274 sg:pub.10.1007/bf00301665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007024239
275 https://doi.org/10.1007/bf00301665
276 rdf:type schema:CreativeWork
277 sg:pub.10.1007/s00381-013-2170-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033912792
278 https://doi.org/10.1007/s00381-013-2170-0
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1001/jama.2013.281053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031488893
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1002/ana.20784 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032399558
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1002/ana.23960 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048919715
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/b978-0-444-52891-9.00038-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013632066
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.ejpn.2012.10.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028768098
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/j.ejpn.2012.12.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006752995
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/j.ejpn.2013.03.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015822271
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/j.pediatrneurol.2012.02.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012443339
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1016/j.pediatrneurol.2013.08.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024394203
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1016/j.pediatrneurol.2013.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039003462
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/j.pediatrneurol.2013.08.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017921616
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/j.pediatrneurol.2013.12.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036207371
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1016/j.tem.2010.05.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045995641
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1016/s0140-6736(08)61279-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028138958
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1016/s0140-6736(12)61134-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019518465
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1016/s0140-6736(12)61767-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1047847005
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1016/s1470-2045(14)70489-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038475260
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1016/s1470-2045(14)71101-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034717349
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1055/s-0030-1269906 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057233391
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1056/nejmoa1001671 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029275718
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1056/nejmoa1100391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002019704
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1056/nejmra055323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028026275
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1158/1078-0432.ccr-11-0445 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003978738
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1177/088307389801301206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012252699
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1212/01.wnl.0000142039.14522.1a schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346426
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1212/wnl.0b013e3182815428 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064357524
331 rdf:type schema:CreativeWork
332 https://doi.org/10.2174/157015912804143595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078738365
333 rdf:type schema:CreativeWork
334 https://doi.org/10.3171/2013.9.peds13193 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071079237
335 rdf:type schema:CreativeWork
336 https://www.grid.ac/institutes/grid.13339.3b schema:alternateName Medical University of Warsaw
337 schema:name Children’s Memorial Health Institute, Warsaw, Poland
338 Department of Pediatric Neurology, Medical University of Warsaw, Warsaw, Poland
339 rdf:type schema:Organization
340 https://www.grid.ac/institutes/grid.15585.3c schema:alternateName Novartis (Italy)
341 schema:name Novartis Farma S.p.A., Origgio, Italy
342 rdf:type schema:Organization
343 https://www.grid.ac/institutes/grid.410566.0 schema:alternateName Ghent University Hospital
344 schema:name Ghent University Hospital, Ghent, Belgium
345 rdf:type schema:Organization
346 https://www.grid.ac/institutes/grid.410569.f schema:alternateName Universitaire Ziekenhuizen Leuven
347 schema:name Gasthuisberg University Hospitals Leuven, Leuven, Belgium
348 rdf:type schema:Organization
349 https://www.grid.ac/institutes/grid.411477.0 schema:alternateName Azienda Ospedaliera Universitaria Senese
350 schema:name Pediatric Unit, University Hospital, Siena, Italy
351 rdf:type schema:Organization
352 https://www.grid.ac/institutes/grid.412826.b schema:alternateName University Hospital in Motol
353 schema:name Motol University Hospital, Prague, Czech Republic
354 rdf:type schema:Organization
355 https://www.grid.ac/institutes/grid.42399.35 schema:alternateName Centre Hospitalier Universitaire de Bordeaux
356 schema:name CHU Pellegrin–Hôpital des Enfants, Bordeaux, France
357 rdf:type schema:Organization
358 https://www.grid.ac/institutes/grid.427987.7 schema:alternateName Bethesda Gyermekkórház
359 schema:name National Institute of Neurosciences, Budapest, Hungary
360 Neurology Department, Bethesda Children’s Hospital, Bethesda Street 3, H-1146, Budapest, Hungary
361 rdf:type schema:Organization
362 https://www.grid.ac/institutes/grid.476612.0 schema:alternateName Novartis (Spain)
363 schema:name Novartis Farmacéutica SA, Barcelona, Spain
364 rdf:type schema:Organization
365 https://www.grid.ac/institutes/grid.7644.1 schema:alternateName University of Bari Aldo Moro
366 schema:name Neonatology and NICU Section, DIMO, University of Bari, Bari, Italy
367 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...